Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration
Version of Record online: 12 OCT 2004
Copyright © 1995 Wiley-Liss, Inc.
Volume 21, Issue 2, pages 140–148, October 1995
How to Cite
Wise, R. A., Leone, P., Rivest, R. and Leeb, K. (1995), Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse, 21: 140–148. doi: 10.1002/syn.890210207
- Issue online: 12 OCT 2004
- Version of Record online: 12 OCT 2004
- Manuscript Revised: 10 APR 1995
- Manuscript Accepted: 10 APR 1995
- Manuscript Received: 29 NOV 1994
Extracellular dopamine and DOPAC (3,4-dihydroxyphenylacetic acid) levels in nucleus accumbens were sampled by microdialysis and quantified with high- performance liquid chromatography during intravenous heroin self-administration sessions in rats. Dopamine levels in 10 and 20 min samples were elevated following the first injection of each session, reaching a plateau of elevation within the first two or three injections and falling back toward baseline only when drug access was terminated. Elevations were in the range of 150–300% when unit dosages of 0.05–0.2 mgkg were given. Increasing the work requirement from FR-1 to FR-10 did not appear to alter the degree of elevation of dopamine levels, and dopamine levels fell during extinction while lever-pressing rates increased 20-fold. While animals compensated for unit dose changes between 0.05 and 0.2 mg/kg/injection, adjusting their response rate such that the same hourly drug intake and the same asymptotic dopamine levels were maintained across these conditions, at 0.4 mg/kg/injection hourly drug intake and asymptotic dopamine levels were elevated beyond the levels sustained by the lower doses. These findings confirm that self-administered doses of intravenous heroin are sufficient to activate the mesolimbic dopamine system and suggest that significant heroin “craving” can emerge when dopamine levels are still moderately elevated, long before the development of dopamine depletion associated with opiate withdrawal. © 1995 Wiley-Liss, Inc.